Martins Ryan's Form 4 filing
89bio, Inc. (ETNB) · filed Feb 22, 2023
- Accession no.
- 0000899243-23-005877
- Filed
- Feb 22, 2023
- Trade date
- Feb 17-21, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $35.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Martins RyanCIK 0001792018 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | FTax withholdingDisposed | −1,750 | $13.97 | −$24,447.5 | 61,118 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −2,540 | $13.89F2 | −$35,280.6 | 58,578 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $13.72 to $14.32. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.